1. Home
  2. PHVS vs BFC Comparison

PHVS vs BFC Comparison

Compare PHVS & BFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • BFC
  • Stock Information
  • Founded
  • PHVS 2015
  • BFC 1894
  • Country
  • PHVS Netherlands
  • BFC United States
  • Employees
  • PHVS N/A
  • BFC N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • BFC Major Banks
  • Sector
  • PHVS Health Care
  • BFC Finance
  • Exchange
  • PHVS Nasdaq
  • BFC Nasdaq
  • Market Cap
  • PHVS 1.0B
  • BFC 990.6M
  • IPO Year
  • PHVS 2021
  • BFC N/A
  • Fundamental
  • Price
  • PHVS $17.11
  • BFC $101.31
  • Analyst Decision
  • PHVS Strong Buy
  • BFC Hold
  • Analyst Count
  • PHVS 5
  • BFC 1
  • Target Price
  • PHVS $41.60
  • BFC $104.00
  • AVG Volume (30 Days)
  • PHVS 49.2K
  • BFC 19.4K
  • Earning Date
  • PHVS 11-13-2024
  • BFC 01-21-2025
  • Dividend Yield
  • PHVS N/A
  • BFC 1.63%
  • EPS Growth
  • PHVS N/A
  • BFC N/A
  • EPS
  • PHVS N/A
  • BFC 6.50
  • Revenue
  • PHVS N/A
  • BFC $158,246,000.00
  • Revenue This Year
  • PHVS N/A
  • BFC N/A
  • Revenue Next Year
  • PHVS N/A
  • BFC $6.27
  • P/E Ratio
  • PHVS N/A
  • BFC $15.61
  • Revenue Growth
  • PHVS N/A
  • BFC N/A
  • 52 Week Low
  • PHVS $15.21
  • BFC $74.90
  • 52 Week High
  • PHVS $33.00
  • BFC $110.49
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 38.75
  • BFC 49.18
  • Support Level
  • PHVS $17.11
  • BFC $98.39
  • Resistance Level
  • PHVS $18.70
  • BFC $103.50
  • Average True Range (ATR)
  • PHVS 1.10
  • BFC 2.03
  • MACD
  • PHVS -0.07
  • BFC 0.36
  • Stochastic Oscillator
  • PHVS 34.65
  • BFC 59.36

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

Share on Social Networks: